PictorLabs, a Los Angeles-based AI histopathology company, raised $30M in Series B funding.

The round was led by Insight Partners, with M Ventures also participating. The funds will enhance technology and expand market reach.

CEO Yair Rivenson stated the company aims to accelerate AI adoption in histopathology, improving patient outcomes. Their software enables countless tests from a single specimen, aiding research, pharma, and clinical fields.

Spun off from UCLA, PictorLabs delivers digitally stained slides rapidly, offering valuable insights for better-informed tissue examinations.